Link to this page
Orphanet Rare Disease Ontology
Last uploaded:
December 4, 2024
Jump to:
Id | http://www.orpha.net/ORDO/Orphanet_2137
http://www.orpha.net/ORDO/Orphanet_2137
|
---|---|
Preferred Name | Autoimmune hepatitis |
Definitions |
A rare liver disease characterized by immune-mediated, acute or chronic liver inflammation, clinically presenting as cryptogenic hepatitis, with interface hepatitis on histological examination, elevated serum aminotransferase levels, and hypergammaglobulinemia / elevated immunoglobulin G, in the presence or absence of specific circulating autoantibodies. Patients may be asymptomatic, chronically ill, or present with acute liver failure. Concurrent autoimmune diseases are frequently observed.
|
Synonyms |
AIH
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition_citation | Orphanet |
---|---|
definition | A rare liver disease characterized by immune-mediated, acute or chronic liver inflammation, clinically presenting as cryptogenic hepatitis, with interface hepatitis on histological examination, elevated serum aminotransferase levels, and hypergammaglobulinemia / elevated immunoglobulin G, in the presence or absence of specific circulating autoantibodies. Patients may be asymptomatic, chronically ill, or present with acute liver failure. Concurrent autoimmune diseases are frequently observed. |
label |
Autoimmune hepatitis
|
prefLabel |
Autoimmune hepatitis
|
hasDbXref |
ICD-10:K75.4
UMLS:C4721555
ICD-11:DB96.0
MedDRA:10003827
|
notation |
ORPHA:2137
|
alternative_term |
AIH
|
present_in |
New Zealand AND has_point_prevalence_average_value : 24.5 AND has_point_prevalence_range : 1-5 / 10 000
Europe AND has_annual_incidence_average_value : 0.75 AND has_annual_incidence_range : 1-9 / 1 000 000
Norway AND has_point_prevalence_average_value : 16.9 AND has_point_prevalence_range : 1-5 / 10 000
Sweden AND has_annual_incidence_average_value : 0.85 AND has_annual_incidence_range : 1-9 / 1 000 000
Norway AND has_annual_incidence_average_value : 1.9 AND has_annual_incidence_range : 1-9 / 100 000
Spain AND has_point_prevalence_average_value : 11.6 AND has_point_prevalence_range : 1-5 / 10 000
Spain AND has_annual_incidence_average_value : 0.95 AND has_annual_incidence_range : 1-9 / 1 000 000
Denmark AND has_point_prevalence_average_value : 23.9 AND has_point_prevalence_range : 1-5 / 10 000
Denmark AND has_annual_incidence_average_value : 1.68 AND has_annual_incidence_range : 1-9 / 100 000
Singapore AND has_point_prevalence_average_value : 4.0 AND has_point_prevalence_range : 1-9 / 100 000
Worldwide AND has_point_prevalence_average_value : 23.5 AND has_point_prevalence_range : 1-5 / 10 000
Israel AND has_point_prevalence_average_value : 11.0 AND has_point_prevalence_range : 1-5 / 10 000
Specific population AND has_point_prevalence_average_value : 42.9 AND has_point_prevalence_range : 1-5 / 10 000
Israel AND has_annual_incidence_average_value : 0.67 AND has_annual_incidence_range : 1-9 / 1 000 000
Worldwide AND has_annual_incidence_average_value : 1.2 AND has_annual_incidence_range : 1-9 / 100 000
Sweden AND has_point_prevalence_average_value : 10.7 AND has_point_prevalence_range : 1-5 / 10 000
Europe AND has_point_prevalence_range : 1-5 / 10 000
See more
See less
|
part_of | |
prefixIRI |
ORDO:Orphanet_2137
|
expertlink | |
subClassOf | |
type | |
has_inheritance |
Not applicable
|
has_age_of_onset |
Adolescent
Adult
Childhood
Elderly
|
treeView |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |